Merck has reported results for second quarter ended June 30, 2012.

On standalone basis, the company has posted a rise of 14.36% in its net profit at Rs 20.15 crore for the quarter ended June 30, 2012 as compared to Rs 17.62 crore for the same quarter in the previous year.  Total income has increased by 15.64% at Rs 185.32 crore for quarter under review as compared to Rs 160.26 crore for the quarter ended June 30, 2011.

Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.

Procter&Gamble Healt Share Price

5196.40 -37.85 (-0.72%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.